Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5651
Valneva
VALN
$537M
| $294K | ﹤0.01% |
56,217
+9,292
| +20% | +$52.8K |
2021 Q3
19 quarters
|
|
5652
Invesco Floating Rate Municipal Income ETF
PVI
$33.6M
| $292K | ﹤0.01% |
11,731
-1,450
| -11% | -$36K |
2013 Q2
52 quarters
|
|
|
TRLV
5653
Trulieve Cannabis Corp
TRLV
$1.92B
| $292K | ﹤0.01% |
+29,697
| New | +$286K |
2026 Q2
0 quarters
|
|
5654
Biote Corp
BTMD
$32.4M
| $291K | ﹤0.01% |
153,907
-34,293
| -18% | -$70.7K |
2023 Q2
12 quarters
|
|
5655
TrueShares S&P Autocallable Defensive Income ETF
PAYM
$132M
| $289K | ﹤0.01% |
11,521
-18,143
| -61% | -$457K |
2026 Q1
1 quarter
|
|
5656
First Trust Alerian US NextGen Infrastructure ETF
RBLD
$42.1M
| $289K | ﹤0.01% |
3,209
-47
| -1% | -$4.12K |
2013 Q4
50 quarters
|
|
5657
SR Bancorp
SRBK
$135M
| $289K | ﹤0.01% |
14,664
-394
| -3% | -$7.28K |
2025 Q1
5 quarters
|
|
5658
Tema Space Innovators ETF
NASA
$4.56B
| $286K | ﹤0.01% |
+9,424
| New | +$301K |
2026 Q2
0 quarters
|
|
5659
Quantum-Si Incorporated
QSI
$304M
| $286K | ﹤0.01% |
323,482
+193,542
| +149% | +$184K |
2021 Q1
21 quarters
|
|
5660
TherapeuticsMD
TXMD
$22.8M
| $286K | ﹤0.01% |
129,217
| – | – |
2013 Q2
52 quarters
|
|
5661
Strawberry Fields REIT
STRW
$184M
| $285K | ﹤0.01% |
20,727
-1,829
| -8% | -$23.8K |
2023 Q1
13 quarters
|
|
5662
Applied Finance Valuation Large Cap ETF
VSLU
$576M
| $285K | ﹤0.01% |
+6,161
| New | +$281K |
2026 Q2
0 quarters
|
|
5663
GigaMedia
GIGM
$13.8M
| $282K | ﹤0.01% |
187,206
-10,400
| -5% | -$14.9K |
2013 Q4
50 quarters
|
|
5664
AB Core Plus Bond ETF
CPLS
$194M
| $282K | ﹤0.01% |
8,011
+170
| +2% | +$5.98K |
2025 Q1
5 quarters
|
|
5665
Invesco CurrencyShares Canadian Dollar Trust
FXC
$65.2M
| $281K | ﹤0.01% |
4,081
-726
| -15% | -$51.3K |
2013 Q2
52 quarters
|
|
5666
Range Nuclear Renaissance Index ETF
NUKZ
$658M
| $279K | ﹤0.01% |
4,093
+548
| +15% | +$38.7K |
2024 Q2
8 quarters
|
|
5667
PDS Biotechnology
PDSB
$102M
| $277K | ﹤0.01% |
313,922
+310,000
| +7,904% | +$329K |
2020 Q3
23 quarters
|
|
5668
Swiss Helvetia Fund
SWZ
$74.2M
| $276K | ﹤0.01% |
46,500
-5,024
| -10% | -$30.1K |
2013 Q2
52 quarters
|
|
5669
Formula Systems
FORTY
$1.76B
| $276K | ﹤0.01% |
2,707
-1
| -0% | -$128 |
2013 Q4
50 quarters
|
|
5670
Innovator US Equity Power Buffer ETF August
PAUG
$1.05B
| $276K | ﹤0.01% |
6,043
| – | – |
2020 Q4
22 quarters
|
|
5671
ChargePoint
CHPT
$179M
| $276K | ﹤0.01% |
46,637
-4,708
| -9% | -$30.8K |
2019 Q4
26 quarters
|
|
5672
Gyre Therapeutics
GYRE
$686M
| $275K | ﹤0.01% |
41,691
+33,050
| +382% | +$225K |
2024 Q1
9 quarters
|
|
5673
Simplify Hedged Equity ETF
HEQT
$322M
| $274K | ﹤0.01% |
8,155
+1
| +0% | +$33 |
2024 Q1
9 quarters
|
|
5674
Global X India Active ETF
NDIA
$47.9M
| $273K | ﹤0.01% |
10,000
| – | – |
2025 Q4
2 quarters
|
|
5675
XMAX Inc
XMAX
$546M
| $273K | ﹤0.01% |
29,992
+24,633
| +460% | +$198K |
2025 Q4
2 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.